New Analyses from Pivotal Phase 3 Trials of Oral Ozanimod to Be Presented at ECTRIMS 2018

Ozanimod showed effects on cognitive processing speed in a post hoc analysis of 12month data from SUNBEAM pivotal trial In separate post hoc analysis of pooled data from phase 3 RADIANCE Part B and SUNBEAM trials ozanimod red...